share_log

4: Statement of changes in beneficial ownership of securities-Director Lewis-Hall Freda C

SEC ·  Dec 21 06:10

Summary by Futu AI

Freda C Lewis-Hall, associated with Conduit Pharmaceuticals, has reported an upcoming transaction scheduled for December 18, 2024. The nature and details of this transaction have not been disclosed in the current filing.The reporting person's address is listed as 4851 Tamiami Trail North, Suite 200, Naples, FL, 34103. While the filing indicates a future event, it does not specify the type of securities involved or the quantity to be transacted. The relationship between Lewis-Hall and the issuer has not been explicitly stated in this announcement.
Freda C Lewis-Hall, associated with Conduit Pharmaceuticals, has reported an upcoming transaction scheduled for December 18, 2024. The nature and details of this transaction have not been disclosed in the current filing.The reporting person's address is listed as 4851 Tamiami Trail North, Suite 200, Naples, FL, 34103. While the filing indicates a future event, it does not specify the type of securities involved or the quantity to be transacted. The relationship between Lewis-Hall and the issuer has not been explicitly stated in this announcement.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated